van Golen KL - Search Results

1

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. van Golen KL, et al. Cancer Res. 2000 Oct 15;60(20):5832-8. Cancer Res. 2000. PMID: 11059780

2

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.

Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Kleer CG, et al. Among authors: van golen kl. Am J Pathol. 2002 Feb;160(2):579-84. doi: 10.1016/S0002-9440(10)64877-8. Am J Pathol. 2002. PMID: 11839578 Free PMC article.

3

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. Kleer CG, et al. Among authors: van golen kl. Oncogene. 2002 May 9;21(20):3172-80. doi: 10.1038/sj.onc.1205462. Oncogene. 2002. PMID: 12082632

4

Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. van Golen KL, et al. Clin Exp Metastasis. 2002;19(4):301-11. doi: 10.1023/a:1015518114931. Clin Exp Metastasis. 2002. PMID: 12090470 Free article.

5

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Pan Q, et al. Among authors: van golen kl. Cancer Res. 2002 Sep 1;62(17):4854-9. Cancer Res. 2002. PMID: 12208730

6

Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. van Golen KL, et al. Mol Cancer Ther. 2002 Jun;1(8):575-83. Mol Cancer Ther. 2002. PMID: 12479217

7

Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.

Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Lin M, et al. Among authors: van golen kl. Mol Cancer. 2005 Jun 21;4(1):21. doi: 10.1186/1476-4598-4-21. Mol Cancer. 2005. PMID: 15969750 Free PMC article.

8

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.

Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. Kleer CG, et al. Among authors: van golen kl. Breast Cancer Res Treat. 2005 Sep;93(2):101-10. doi: 10.1007/s10549-005-4170-6. Breast Cancer Res Treat. 2005. PMID: 16187229 Free article.

9

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD. van Golen KL, et al. Clin Cancer Res. 1999 Sep;5(9):2511-9. Clin Cancer Res. 1999. PMID: 10499627

10

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD. van Golen KL, et al. Neoplasia. 2000 Sep-Oct;2(5):418-25. doi: 10.1038/sj.neo.7900115. Neoplasia. 2000. PMID: 11191108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters